India's P&G Hygiene and Health profit drops as costs bite

By Reuters News

- Procter & Gamble Hygiene and Health Care PROC.NS reported a 7% decline in quarterly profit on Thursday as the Indian consumer goods maker battled raw material and energy cost inflation brought on by the Middle East crisis.

The fallout from the conflict has driven up energy and freight costs, raised commodity prices and strained supply chains, with corporates globally jacking up prices to counter the margin squeeze.


Here are more details:

  • For P&G Hygiene and Health Care, a subsidiary of American consumer goods group Procter & Gamble PG.N, profit dropped to 1.96 billion rupees ($20.93 million) for the second quarter ended September 30, from 2.1 billion rupees, a year earlier.

  • Shares in the Indian maker of Vicks lozenges and Whisper sanitary pads fell nearly 4% after results. They were last down 1.4% at 7,099.50 rupees.

  • Higher raw material and energy costs weighed on profit during the quarter, P&G Hygiene and Health Care said.

  • "The macro-economic landscape remains challenging," Managing Director Kumar Venkatasubramanian said.

  • Revenue from operations slipped marginally to 11.45 billion rupees.

  • Several bellwethers including Hindustan Unilever HLL.NS and Nestle India NEST.NS have also flagged commodity inflation with the industry turning to reduced pack sizes and price increases to boost profits.

($1 = 93.6400 Indian rupees)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.